-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203.P1.27 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I

Symposia: Lymphocytes and Acquired or Congenital Immunodeficiency Disorders Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)
This symposium will highlight cutting-edge pre-clinical and clinical studies aimed at increasing our understanding of lymphocytes and their contribution to the pathophysiology of acquired or congenital immunodeficiency disorders.

De Zhou, MD1,2,3,4*, Xianbo Huang, MD, PhD1,2,3,4*, Xueying Li1,2,3,4*, Lixia Zhu1,2,3,4*, Mixue Xie1,2,3,4*, Xin Huang, Ph.D.1,2*, Fang Yu5*, Juying Wei1,2,3,4*, Liya Ma, M.D.1,2,3,4*, Xiudi Yang1,2,3,4*, Jianai Sun1,2,3,4*, Li Li1,2,3,4*, Wanzhuo Xie1,2,4,6*, Hongyan Tong, MD, PhD1,2,3,4*, Jie Jin, M.D., Ph.D.1,2,3,4, Honghu Zhu, MD1,2,3,4* and Xiujin Ye, MD1,2,3,4*

1Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China, Hangzhou, China
2Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, PR China, Hangzhou, China
3Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China, Hangzhou, China
4Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China, Hangzhou, China
5Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China, Hangzhou, China
6Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Dandan Wang, MD, MS1, Subramaniam Malarkannan, PhD2,3,4*, Kasiani C. Myers, MD5, Emery H. Bresnick, PhD6,7,8,9, James Verbsky10* and Monica Thakar, MD11,12

1Versiti, Blood Research Institute, The Medical College of Wisconsin, Milwaukee, WI
2Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3Blood Research Institute, Versiti, Milwaukee, WI
4Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI
5Department of Pediatrics, Division of Bone Marrow Transplantation and Immune Deficieny, Cincinnati Children's Hospital, Cincinnati, OH
6Wisconsin Blood Cancer Research Institute, Department of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, WI
7UW-Madison Blood Research Program, Department of Cell and Regenerative Biology; UW Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI
8Wisconsin Blood Cancer Research Institute, Department of Cell and Regenerative Biology, Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI
9University of Wisconsin, Middleton, WI
10Medical College of Wisconsin, Milwaukee, WI
11Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
12Clinical Research Division, Fred Hutchinson Cancer Research Center, and Department of Pediatrics, University of Washington, Seattle, WA

Ailin Zhao1*, Xin Wang1*, Mengshi Hu2*, Lijuan Chen, PhD2* and Ting Niu1

1Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P.R. China, Chengdu, Sichuan, China
2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center, Chengdu, Sichuan, 610041, P.R. China, Chengdu, Sichuan, China

Ulrich Salzer, MD1*, Christoph B. Geier, MD, MSc1*, Maryssa Ellison, BS2*, Melis Yilmaz, MMSc2,3*, Caroline von Spee-Mayer, MD4*, Carsten Speckmann, MD4,5*, Stephan Ehl, MD, PhD4,5*, Olaf Neth, MD, PhD6*, Ana Pilar Garcia Garcia, MD7,8,9*, Angela Deya Martinez, MD7,8,9*, Laia Alsina, MD, PhD7,8,9*, Katja Sockel, MD10*, Catharina Schuetz, MD, MSc11,12*, David E. Potts, MMSc13*, Boglarka Ujhazi, MS13*, Krisztian Csomos, PhD13*, Jolan E. Walter, MD, PhD2,3,14* and Klaus Warnatz, MD1*

1Department of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, Freiburg, Germany
2Division of Allergy and Immunology, Departments of Pediatrics and Medicine, University of South Florida Morsani College of Medicine, St. Petersburg, FL
3Division of Allergy and Immunology, Departments of Pediatrics, Johns Hopkins All Children's Hospital, St. Petersburg, FL
4Center of Chronic Immunodeficiency, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
5Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
6Paediatric Infectious Diseases, Rheumatology and Immunology Unit, University Hospital Virgen del Rocio, Institute of Biomedicine, Seville, Spain
7Clinical Immunology Unit, Hospital Sant Joan de Déu-Hospital Clínic Barcelona, Barcelona, Spain
8Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain
9Institut de Recerca Sant Joan de Déu, Barcelona, Spain
10Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany
11Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
12Universitäts Centrum für Seltene Erkrankungen, University Hospital Carl-Gustav-Carus, Technische Universität Dresden, Dresden, Germany
13University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, FL
14Division of Allergy and Immunology, Massachusetts General Hospital for Children, Boston, MA

Moraima Jiménez, MD1,2*, Sandra Novoa Jáuregui, MD1*, Candela Fernández-Naval, PhD3*, Marc Bosch Schips, MD1*, Sofía Muzio, MD1*, Víctor Navarro Garcés4*, Cristina Andrés, PhD3*, Mónica Martínez-Gallo, PhD5*, Andrés Antón3*, Alba Cabirta1*, Angel Serna, MD1*, Daniel Medina2,6*, Soraya Peralta2,6*, Gemma Pujadas2,6*, Cristina Hernandez2,6*, Carlota Pagès, MSc2,6*, Tomás Pumarola3*, Mercedes Valentín1*, David Valcárcel, MD, PhD7, Manuel Hernández8*, Isabel Ruiz-Camps, MD, PhD9*, Marta Crespo, PhD2,6*, Juliana Esperalba, PhD3*, Pau Abrisqueta, MD, PhD1,2* and Francesc Bosch, MD, PhD1,2,6

1Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
2Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
3Department of Microbiology, Vall d’Hebron Hospital Universitari, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
4Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), BARCELONA, Spain
5Department of Immunology, Vall d’Hebron Hospital Universitari, Vall d’Hebron Research Institute, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
6Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
7Hospital Universitari Vall d’Hebron, Barcelona, Spain
8Department of Immunology, Vall d’Hebron Hospital Universitari, Vall d’Hebron Research Institute, Vall d’Hebron Barcelona Hospital Campus. Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UA), Barcelona, Spain
9Department of Infectious Diseases, Vall d´Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain

Cilia R. Pothast1*, Romy C. Dijkland, MSc1*, Melissa Thaler2*, Renate S. Hagedoorn, ing.3*, Michel G.D. Kester1*, Anne K. Wouters1*, Pieter S. Hiemstra, PhD4*, Martijn J. van Hemert, PhD2*, Stephanie Gras, PhD5*, J.H. Frederik Falkenburg1* and Mirjam H.M. Heemskerk1

1Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
2Department of Microbiology, Leiden University Medical Center, Leiden, Netherlands
3Department of Hematology, Leiden University Medical Center (LUMC), Leiden, Netherlands
4Leiden University Medical Center, Leiden, NLD
5Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, Melbourne, Australia

Masashi Nishikubo, MD1*, Yoshimitsu Shimomura, MD1*, Ryusuke Yamamoto, MD, PhD1*, Hayato Maruoka, MHS2*, Seiko Nasu, AS2*, Tomomi Nishioka, Diploma3*, Kenji Sakizono, Diploma1*, Satoshi Mitsuyuki, MD1*, Tomoyo Kubo, MD1*, Naoki Okada, MD1*, Daishi Nakagawa, MD1*, Kimimori Kamijo, MD1*, Hiroharu Imoto, MD1*, Yuya Nagai, MD, PhD1*, Nobuhiro Hiramoto, MD1*, Satoshi Yoshioka, MD, PhD1, Noboru Yonetani, MD1*, Tadakazu Kondo, MD, PhD1 and Takayuki Ishikawa1

1Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
2Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan
3LSI medience Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan

Tsung-Chih Chen1,2,3*, Chia-Lang Hsu, Dr4*, Chi-Yuan Yao, M.D.2,5*, Yu-Ren Chen5*, Yueh-Chwen Hsu, PhD5*, Chein-Jun Kao5*, Hsin-An Hou, MD, PhD3*, Wen-Chien Chou, MD, PhD3,5 and Hwei-Fang Tien, MD, PhD3

1Division of Hematology/Medical Oncology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
2Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
3Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
4Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan
5Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

Rushil Shah1*, Xanthi-Leda Katopodi, MS2*, Anthos Christofides, MD1,3*, Rinku Pal, MS4*, Ioannis Vlachos, PhD2,5,6*, Nikolaos Patsoukis, PhD1* and Vassiliki A Boussiotis, MD, PhD1

1Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
3Department of Medicine, Yale University, New Haven, CT
4Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA
5Broad Institute of MIT and Harvard, Cambridge, MA
6Spatial Technologies Unit, Harvard Medical School Initiative for RNA Medicine, Boston, MA

*signifies non-member of ASH